The Patent Finder

Method for treating glucose related disorders using stem cell-derived gastro-intestinal cells

Incube Labs, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 61/342,029, filed Apr 7, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,398,737Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells
In force
 · Low confidence
Incube Labs, LLCIn force
Low confidence
US 11,077,146Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells
In force
 · Low confidence
Incube Labs, LLCIn force
Low confidence
US 9,144,586Method for treating glucose related disorders using stem cell-derived gastro-intestinal cells
In force
 · High confidence
Incube Labs, LLCIn force
High confidence
US 12,115,195Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells
In force
 · Low confidence
Incube Labs, LLCIn force
Low confidence
US 9,617,518Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells
Lapsed Apr 11, 2025 on the fee record
High confidence
Incube Labs, LLCLapsed Apr 11, 2025 on the fee record
High confidence
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Incube Labs, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited